TGA Approval

TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial (425612)

ARTG ID

425612

ARTG Name

TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial

Sponsor

Sandoz Pty Ltd

ARTG Date

April 4, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Sandoz Pty Ltd.

Ingredient Name

Natalizumab

Empowering clinical research with data-driven insights and AI-powered tools.

TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial (425612) - TGA 批准文号 | MedPath